Synthetic glycopeptide-based delivery systems for systemic gene targeting to hepatocytes.

作者: Khursheed Anwer , Mark Logan , Frank Tagliaferri , Manpreet Wadhwa , Oscar Monera

DOI: 10.1023/A:1007533121682

关键词:

摘要: Purpose. To design, synthesize, and test synthetic glycopeptide-baseddelivery systems for gene targeting to hepatocytes by systemicadministration.Methods. All peptides were synthesized the solid phase methoddeveloped using Fmoc chemistry on a peptide synthesizer. The bindingof galactosylated HepG2 cells accessibility of thegalactose residues particle surface was demonstrated acompetition assay 125I-labeleld asialoorosomucoid RCA lectinagglutination assay, respectively. DNA plasmid encoding chloramphenicolacetyl transferase (CAT) complexed with tri-galactosylatedpeptide (GM245.3) or tri-galactosylated lipopeptide (GM246.3) in thepresence an endosomolytic (GM225.1) endosomolyticlipopeptide (GM227.3) obtain particles 100–150 nm insize. plasmid/peptide complexes added cell culturesor intravenously administered tail vein injection into normal miceor rats. Plasmid uptake expression quantified qPCR andELISA, respectively.Results. Multiple antennary glycopeptides that have ability tocondense deliver andcomplexed colloidally stable DNA/peptidecomplexes. Addition DNA/GM245.3/GM225.1 complexes(1:3:1 (−/+/−)) cultures yielded CAT intransfected cells. transfection efficiency significantly reducedin absence galactose ligand removal peptide.Intravenous administration DNA/GM245.3 (1:0.5(−/+)) rats theliver. Substitution GM245.3 GM246.3resulted more particles, 10-fold enhancement inliver uptake. detectable liver followingintravenous DNA/GM246.3 complexes. ofendosomolytic GM227.3 complexes(DNA/GM246.3/GM227.3 (1:0.5:1 (−/+/−))) 5-fold increase inCAT expression. Liver 8-fold 40-fold higher thanlung spleen, respectively, localized only.The enhanced increasing DNAdose volume. liverusing DNA/GM246.3/GM227.3 100-200-fold higherthan formulated glucose. Tissue examination serumbiochemistry did not show any adverse effect after intravenous delivery.Conclusions. Gene achieved systemicadministration well-tolerated system. this glycopeptide deliverysystem dependent structure, activity,colloidal stability,

参考文章(19)
A L Schwartz, S E Fridovich, H F Lodish, Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. Journal of Biological Chemistry. ,vol. 257, pp. 4230- 4237 ,(1982) , 10.1016/S0021-9258(18)34710-0
Khursheed Anwer, Keith A. Earle, Mei Shi, Jijun Wang, Russell J. Mumper, Belinda Proctor, Kimberly Jansa, Harry C. Ledebur, Stephen Davis, William Eaglstein, Alain P. Rolland, Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharmaceutical Research. ,vol. 16, pp. 889- 895 ,(1999) , 10.1023/A:1018834305079
G.Y. Wu, J.M. Wilson, F. Shalaby, M. Grossman, D.A. Shafritz, C.H. Wu, Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. Journal of Biological Chemistry. ,vol. 266, pp. 14338- 14342 ,(1991) , 10.1016/S0021-9258(18)98689-8
John Frese, Catherine H. Wu, George Y. Wu, Targeting of genes to the liver with glycoprotein carriers Advanced Drug Delivery Reviews. ,vol. 14, pp. 137- 152 ,(1994) , 10.1016/0169-409X(94)90009-4
George Y. Wu, Catherine H. Wu, Liver-directed gene delivery Advanced Drug Delivery Reviews. ,vol. 12, pp. 159- 167 ,(1993) , 10.1016/0169-409X(93)90057-B
Dirk Meijer, Grietje Molema, TARGETING OF DRUGS TO THE LIVER Seminars in Liver Disease. ,vol. 15, pp. 202- 256 ,(1995) , 10.1055/S-2007-1007278
Fred D Ledley, Mark R Adams, Humberto E Soriano, Gretchen Darlington, Milton Finegold, Robert Lanford, Dee Carey, Dorothy Lewis, Patricia A Baley, Steve Rothenberg, Mark Kay, Mary Brandt, Robert Moen, W French Anderson, Peter Whitington, William Pokorny, Savio L C Woo, Development of a Clinical Protocol for Hepatic Gene Transfer: Lessons Learned in Preclinical Studies Pediatric Research. ,vol. 33, pp. 313- 320 ,(1993) , 10.1203/00006450-199304000-00001
J. Haensler, F. Schuber, Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages Biochimica et Biophysica Acta. ,vol. 946, pp. 95- 105 ,(1988) , 10.1016/0005-2736(88)90461-0
T. Kawabata, L. Packer, α-Lipoate Can Protect Against Glycation of Serum Albumin, But Not Low-Density Lipoprotein Biochemical and Biophysical Research Communications. ,vol. 203, pp. 99- 104 ,(1994) , 10.1006/BBRC.1994.2154